JPS63192703A - External agent for skin - Google Patents
External agent for skinInfo
- Publication number
- JPS63192703A JPS63192703A JP2439187A JP2439187A JPS63192703A JP S63192703 A JPS63192703 A JP S63192703A JP 2439187 A JP2439187 A JP 2439187A JP 2439187 A JP2439187 A JP 2439187A JP S63192703 A JPS63192703 A JP S63192703A
- Authority
- JP
- Japan
- Prior art keywords
- skin
- formula
- cholesterol
- fatty acid
- surfactant
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 claims abstract description 27
- 235000012000 cholesterol Nutrition 0.000 claims abstract description 15
- 239000000194 fatty acid Substances 0.000 claims abstract description 13
- 235000014113 dietary fatty acids Nutrition 0.000 claims abstract description 12
- 229930195729 fatty acid Natural products 0.000 claims abstract description 12
- 239000000126 substance Substances 0.000 claims abstract description 12
- -1 cholesterol fatty acid ester Chemical class 0.000 claims abstract description 9
- 229920006395 saturated elastomer Polymers 0.000 claims abstract description 9
- 150000002430 hydrocarbons Chemical group 0.000 claims abstract description 8
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims abstract description 8
- 229930195734 saturated hydrocarbon Natural products 0.000 claims abstract description 8
- 229930195735 unsaturated hydrocarbon Natural products 0.000 claims abstract description 8
- 150000004665 fatty acids Chemical class 0.000 claims abstract description 6
- 239000004094 surface-active agent Substances 0.000 claims abstract description 6
- 150000003904 phospholipids Chemical class 0.000 claims abstract description 5
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 claims abstract description 3
- JSPNNZKWADNWHI-PNANGNLXSA-N (2r)-2-hydroxy-n-[(2s,3r,4e,8e)-3-hydroxy-9-methyl-1-[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoctadeca-4,8-dien-2-yl]heptadecanamide Chemical compound CCCCCCCCCCCCCCC[C@@H](O)C(=O)N[C@H]([C@H](O)\C=C\CC\C=C(/C)CCCCCCCCC)CO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O JSPNNZKWADNWHI-PNANGNLXSA-N 0.000 claims abstract 2
- 229930183167 cerebroside Natural products 0.000 claims abstract 2
- RIZIAUKTHDLMQX-UHFFFAOYSA-N cerebroside D Natural products CCCCCCCCCCCCCCCCC(O)C(=O)NC(C(O)C=CCCC=C(C)CCCCCCCCC)COC1OC(CO)C(O)C(O)C1O RIZIAUKTHDLMQX-UHFFFAOYSA-N 0.000 claims abstract 2
- 238000002360 preparation method Methods 0.000 claims description 20
- 125000004432 carbon atom Chemical group C* 0.000 claims description 10
- 238000002156 mixing Methods 0.000 claims description 5
- CRJGESKKUOMBCT-VQTJNVASSA-N N-acetylsphinganine Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(C)=O CRJGESKKUOMBCT-VQTJNVASSA-N 0.000 abstract description 10
- 229940106189 ceramide Drugs 0.000 abstract description 9
- YDNKGFDKKRUKPY-JHOUSYSJSA-N C16 ceramide Natural products CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)C=CCCCCCCCCCCCCC YDNKGFDKKRUKPY-JHOUSYSJSA-N 0.000 abstract description 7
- ZVEQCJWYRWKARO-UHFFFAOYSA-N ceramide Natural products CCCCCCCCCCCCCCC(O)C(=O)NC(CO)C(O)C=CCCC=C(C)CCCCCCCCC ZVEQCJWYRWKARO-UHFFFAOYSA-N 0.000 abstract description 7
- 150000001875 compounds Chemical class 0.000 abstract description 7
- VVGIYYKRAMHVLU-UHFFFAOYSA-N newbouldiamide Natural products CCCCCCCCCCCCCCCCCCCC(O)C(O)C(O)C(CO)NC(=O)CCCCCCCCCCCCCCCCC VVGIYYKRAMHVLU-UHFFFAOYSA-N 0.000 abstract description 7
- 150000002632 lipids Chemical class 0.000 abstract description 5
- 239000003795 chemical substances by application Substances 0.000 abstract description 4
- 239000002736 nonionic surfactant Substances 0.000 abstract description 4
- 150000001408 amides Chemical class 0.000 abstract description 3
- 150000001783 ceramides Chemical class 0.000 abstract description 3
- 206010040849 Skin fissures Diseases 0.000 abstract 1
- 238000013329 compounding Methods 0.000 abstract 1
- 210000003491 skin Anatomy 0.000 description 30
- 239000000203 mixture Substances 0.000 description 20
- 239000003921 oil Substances 0.000 description 10
- 235000019198 oils Nutrition 0.000 description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 10
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 9
- 239000002537 cosmetic Substances 0.000 description 9
- 210000000434 stratum corneum Anatomy 0.000 description 8
- 206010013786 Dry skin Diseases 0.000 description 7
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 239000004615 ingredient Substances 0.000 description 6
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- 235000021355 Stearic acid Nutrition 0.000 description 4
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 4
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 4
- 239000002674 ointment Substances 0.000 description 4
- 239000012071 phase Substances 0.000 description 4
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 4
- 239000008117 stearic acid Substances 0.000 description 4
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 239000000839 emulsion Substances 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- 230000014759 maintenance of location Effects 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 241000283690 Bos taurus Species 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- FLIACVVOZYBSBS-UHFFFAOYSA-N Methyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC FLIACVVOZYBSBS-UHFFFAOYSA-N 0.000 description 2
- 239000004264 Petrolatum Substances 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 239000008346 aqueous phase Substances 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- 210000000736 corneocyte Anatomy 0.000 description 2
- GPLRAVKSCUXZTP-UHFFFAOYSA-N diglycerol Chemical compound OCC(O)COCC(O)CO GPLRAVKSCUXZTP-UHFFFAOYSA-N 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- 239000006210 lotion Substances 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 230000003020 moisturizing effect Effects 0.000 description 2
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 2
- 235000019271 petrolatum Nutrition 0.000 description 2
- 229940066842 petrolatum Drugs 0.000 description 2
- 229940032094 squalane Drugs 0.000 description 2
- 235000015961 tonic Nutrition 0.000 description 2
- 230000001256 tonic effect Effects 0.000 description 2
- 229960000716 tonics Drugs 0.000 description 2
- 229940099259 vaseline Drugs 0.000 description 2
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 1
- LDVVTQMJQSCDMK-UHFFFAOYSA-N 1,3-dihydroxypropan-2-yl formate Chemical compound OCC(CO)OC=O LDVVTQMJQSCDMK-UHFFFAOYSA-N 0.000 description 1
- DGSZGZSCHSQXFV-UHFFFAOYSA-N 2,3-bis(2-ethylhexanoyloxy)propyl 2-ethylhexanoate Chemical compound CCCCC(CC)C(=O)OCC(OC(=O)C(CC)CCCC)COC(=O)C(CC)CCCC DGSZGZSCHSQXFV-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 241000723346 Cinnamomum camphora Species 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- 206010011878 Deafness Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 239000000232 Lipid Bilayer Substances 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- 206010039792 Seborrhoea Diseases 0.000 description 1
- JBBRZDLNVILTDL-XNTGVSEISA-N [(3s,8s,9s,10r,13r,14s,17r)-10,13-dimethyl-17-[(2r)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1h-cyclopenta[a]phenanthren-3-yl] 16-methylheptadecanoate Chemical compound C([C@@H]12)C[C@]3(C)[C@@H]([C@H](C)CCCC(C)C)CC[C@H]3[C@@H]1CC=C1[C@]2(C)CC[C@H](OC(=O)CCCCCCCCCCCCCCC(C)C)C1 JBBRZDLNVILTDL-XNTGVSEISA-N 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 150000005215 alkyl ethers Chemical class 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 125000005037 alkyl phenyl group Chemical group 0.000 description 1
- 125000003368 amide group Chemical group 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 239000002280 amphoteric surfactant Substances 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 239000010775 animal oil Substances 0.000 description 1
- 239000003945 anionic surfactant Substances 0.000 description 1
- 239000000730 antalgic agent Substances 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000003908 antipruritic agent Substances 0.000 description 1
- 239000003212 astringent agent Substances 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 229960000846 camphor Drugs 0.000 description 1
- 229930008380 camphor Natural products 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000008271 cosmetic emulsion Substances 0.000 description 1
- 239000008406 cosmetic ingredient Substances 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 239000012043 crude product Substances 0.000 description 1
- 239000000645 desinfectant Substances 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 239000003974 emollient agent Substances 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 125000004185 ester group Chemical group 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 125000005456 glyceride group Chemical group 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- 150000002314 glycerols Chemical class 0.000 description 1
- 150000002327 glycerophospholipids Chemical class 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 230000003779 hair growth Effects 0.000 description 1
- 239000011874 heated mixture Substances 0.000 description 1
- 229940125697 hormonal agent Drugs 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 229910001410 inorganic ion Inorganic materials 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 229940041616 menthol Drugs 0.000 description 1
- 150000002736 metal compounds Chemical class 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- 239000012299 nitrogen atmosphere Substances 0.000 description 1
- 235000019488 nut oil Nutrition 0.000 description 1
- 239000010466 nut oil Substances 0.000 description 1
- 239000007764 o/w emulsion Substances 0.000 description 1
- 230000037312 oily skin Effects 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 125000000913 palmityl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 230000000284 resting effect Effects 0.000 description 1
- 235000003441 saturated fatty acids Nutrition 0.000 description 1
- 150000004671 saturated fatty acids Chemical class 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/007—Preparations for dry skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/68—Sphingolipids, e.g. ceramides, cerebrosides, gangliosides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Dermatology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Cosmetics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
【発明の詳細な説明】
〔産業上の利用分野〕
本発明は皮膚外用剤、更に詳しくは、角層の水分保持力
を高め、肌あれを改善することのできる皮膚外用剤に関
する。DETAILED DESCRIPTION OF THE INVENTION [Field of Industrial Application] The present invention relates to an external skin preparation, and more particularly to an external skin preparation that can improve the moisture retention of the stratum corneum and improve rough skin.
従来、肌にうるおいを与え、肌を柔軟にするKは、角質
層の水分が重要であることが知られている。そして、当
該水分の保持は、角質層に含まれている水溶性成分、す
なわち遊離アミノ酸、有機酸、尿素又は無機イオンによ
るものであるとされ、これらの物質は単独であるいは組
合せて薬用皮膚外用剤あるいは化粧料に配合して、肌あ
れの改善又は予防の目的で使用されている。It has been known that the moisture in the stratum corneum is important for K, which moisturizes and softens the skin. The retention of moisture is said to be due to water-soluble components contained in the stratum corneum, such as free amino acids, organic acids, urea, or inorganic ions, and these substances may be used alone or in combination in medicated skin preparations. Alternatively, it is used in cosmetics to improve or prevent rough skin.
また、これとは別に水と親和性が高い多くの保湿性物質
が開発され、同様の目的で使用されている。In addition, many other moisturizing substances that have a high affinity for water have been developed and are used for similar purposes.
しかしながら、これらの保湿性物質は、皮膚に適用した
場合、その作用は、皮膚角質上にあって水分を角質に供
給するというもので、しかもその効果は一時的でア)、
根本的に角質層の水分保持能力を改善し、肌あれ全本質
的に予防あるいは治癒させるというものではなかった。However, when these moisturizing substances are applied to the skin, their action is to be on the stratum corneum and supply moisture to the stratum corneum, and their effect is temporary.
It was not intended to fundamentally improve the water retention ability of the stratum corneum and essentially prevent or cure all skin roughness.
斯かる実情において、本発明者らは上記問題点を解決す
べく角質細胞間脂質に注目して鋭意研究を行ったところ
、セラミド又はその類似構造物質及び角質細胞間に存在
する脂質を組合せたものが角質層の水分保持能力を根本
的に改善する効果を奏すること、そして上記混合物に界
面活性剤を併用するとその効果を更に増大できることを
見出し、本発明を完成した。Under these circumstances, the present inventors conducted intensive research focusing on interkeratinocyte lipids in order to solve the above-mentioned problems, and found that a combination of ceramide or a similar structural substance and lipids existing between corneocytes. The present invention was completed based on the discovery that the above mixture has the effect of fundamentally improving the water retention ability of the stratum corneum, and that the effect can be further increased by using a surfactant in combination with the above mixture.
すなわち、本発明は次の成分(A)及び(B)(4)一
般式(1)
(式中 R1及びR1は1個以上の水酸基が置換するこ
とのある炭素数10〜26の直鎖若しくは分岐鎖の飽和
若しくは不飽和の炭化水素基を示す)
で表わされるセラミド又はその類似構造物質の一樵又は
二種以上、
(B) コレステロール、コレステロール脂肪Mエス
テル、脂肪酸、トリグリセリド、セレプロシド又はリン
脂質の一種又は二種以上、を含有することy&:%徴と
する皮膚外用剤を提供するものである。That is, the present invention uses the following components (A) and (B) (4) general formula (1) (wherein R1 and R1 are straight chain or carbon atoms having 10 to 26 carbon atoms which may be substituted with one or more hydroxyl groups) One or more ceramides or similar structural substances represented by (representing branched saturated or unsaturated hydrocarbon groups); (B) cholesterol, cholesterol fatty M esters, fatty acids, triglycerides, cereprosides or phospholipids; The present invention provides an external preparation for skin containing one or more of the following.
本発明で使用されるセラミド(1)は公知の化金物であ
る。また、その類似構造物質とは、2本の長鎖炭化水素
基とそれらの間にOH基とアミド基とを有し、かつ当該
分子が一平面上の立体配座をとることのできる脂質誘導
体を言う。かかる類似構造物質としては、例えば次の一
般式(1)で表わされるアミド誘導体が挙げられる。Ceramide (1) used in the present invention is a known metal compound. In addition, the similar structural substance is a lipid derivative that has two long-chain hydrocarbon groups and an OH group and an amide group between them, and the molecule can assume a uniplanar conformation. say. Examples of such similar structural substances include amide derivatives represented by the following general formula (1).
R”−0−CM。R”-0-CM.
CH,CH,OH
(式中、Rsは炭素数10〜26の直鎖若しくは分岐鎖
の飽和若しくは不飽和の炭化水素基、R4は炭素数9〜
25の直鎖若しくは分岐鎖の飽和若しくは不飽和の炭化
水素基を示す)このアミド誘導体(1)は新規な化合物
であるが、公知の方法〔例えば、?リッシュ・シャーナ
ル・オプ・ケミストリー(Po1.J、Ch・m、);
特開昭54−117421号、同54−144308号
、同54−147937号公報〕に準じて製造すること
ができる。すなわち、次に示される反応式に従って、グ
リシゾルエーテルとエタノールアミンから得られる化合
物(1) t−脂肪酸メチルエステルと反応させる−こ
とによって製造することができる。CH, CH, OH (wherein, Rs is a straight chain or branched saturated or unsaturated hydrocarbon group having 10 to 26 carbon atoms, and R4 is a straight chain or branched saturated or unsaturated hydrocarbon group having 9 to 26 carbon atoms)
Although this amide derivative (1) is a new compound, it can be prepared by known methods [for example, ? Risch Sharnal Op Chemistry (Po1.J, Ch.m,);
It can be manufactured according to JP-A-54-117421, JP-A-54-144308, and JP-A-54-147937. That is, it can be produced by reacting compound (1) obtained from glycisole ether and ethanolamine with t-fatty acid methyl ester according to the reaction formula shown below.
八りh
(式中、R1及びR4は前記と同じ)
コレステロールとしては、次式(ff)で表わされるも
のが最も好ましいが、3位水酸基が残存しているもので
あれば如何なる誘導体も使用できる。(In the formula, R1 and R4 are the same as above.) As the cholesterol, one represented by the following formula (ff) is most preferable, but any derivative can be used as long as the hydroxyl group at the 3-position remains. .
コレステロール脂肪酸エステルとしては、式(V)
(式中 R1は1個以上の水酸基が置換することのある
炭素数1〜25の直鎖若しくは分岐鎖の飽和若しくは不
飽和の炭化水素基を示す)で表わされるものが最も好ま
しいが、3位エステル基が残存しているものであれば如
何なる誘導体も使用できる。The cholesterol fatty acid ester is represented by formula (V) (wherein R1 represents a straight or branched saturated or unsaturated hydrocarbon group having 1 to 25 carbon atoms which may be substituted with one or more hydroxyl groups). The one shown is most preferred, but any derivative in which the 3-position ester group remains can be used.
脂肪酸としては一般式(■)
R’−COOH(Vl)
(式中 R6は1個以上の水酸基が置換することのある
炭素数1〜25の直鎖若しくは分岐鎖の飽和若しくは不
飽和の炭化水素基を示す)で表わされるものが使用でき
るが、炭素数14〜18の直鎖の飽和若しくは不飽和の
脂肪酸が最適である。The fatty acid has the general formula (■) R'-COOH (Vl) (where R6 is a straight or branched saturated or unsaturated hydrocarbon having 1 to 25 carbon atoms which may be substituted with one or more hydroxyl groups). (indicating a group) can be used, but linear saturated or unsaturated fatty acids having 14 to 18 carbon atoms are most suitable.
トリグリセリドとしては一般式(■)
(式中 Hl 、Ha 、 R1は1個以上の水酸基が
置換することのある炭素数1〜25の直鎖若しくは分岐
鎖の飽和若しくは不飽和の炭化水素基を示す)
で表わされるものが使用できる。The triglyceride has the general formula (■) (where Hl, Ha, and R1 represent a straight or branched saturated or unsaturated hydrocarbon group having 1 to 25 carbon atoms, which may be substituted with one or more hydroxyl groups). ) can be used.
セレプロシドは、前記式(1)のセラミドに糖が付加し
た複合脂質であシ、一般式(■)R”−CH−0X
(式中、Xはグルコース、ラクトース等の塘を示し R
1、R1は前記と同じ)
で表わされる。Celeproside is a complex lipid in which sugar is added to the ceramide of the formula (1), and has the general formula (■)R''-CH-0X (wherein, X represents a substance such as glucose or lactose)
1, R1 is the same as above).
リン脂質には、大別するとグリセリン誘導体であるグリ
セロリン脂質とセラミド誘導体であるスフィンゴリン脂
質があるが、本発明にはその何れに含まれるものも使用
できる。Phospholipids can be broadly classified into glycerophospholipids, which are glycerin derivatives, and sphingophospholipids, which are ceramide derivatives, and any of these can be used in the present invention.
本発明O皮膚外用剤への(A)成分及び(B)成分の配
合比は、重量比で8=2〜2:8が好ましい。これらを
配合するには、両者を上記比率で混合して一旦加熱溶解
後冷却してペースト状あるいは固体状としたものを他の
成分に添加するのが好ましいが、またそれぞれを別個に
添加してもよい。The blending ratio of component (A) and component (B) in the external skin preparation of the present invention is preferably 8=2 to 2:8 in terms of weight ratio. To blend these, it is preferable to mix both in the above ratio, heat and melt, then cool to form a paste or solid, which is then added to the other ingredients, but it is also preferable to add each separately. Good too.
成分(A)と成分(B)の混合物の本発明皮膚外用剤へ
の配合量は、特に制限されないが、通常乳化型の皮膚外
用剤の場合には全組成の0.01〜60重景%(以下単
に%で示す)、特に0.1〜30%が好ましく、またス
クワラン等の液状炭化水素を基剤とする油性の皮膚外用
剤の場合には1〜90%、特に5〜50%が好ましい。The amount of the mixture of component (A) and component (B) in the skin preparation of the present invention is not particularly limited, but in the case of an emulsion-type skin preparation, it is usually 0.01 to 60% by weight of the total composition. (hereinafter simply expressed as %), preferably 0.1 to 30%, and in the case of oily skin preparations based on liquid hydrocarbons such as squalane, 1 to 90%, especially 5 to 50%. preferable.
本発明の効果を更に増大するために併用される界面活性
剤としては、非イオン界面活性剤、陰イオン界面活性剤
、両性界面活性剤の何れをも使用できるが、就中非イオ
ン界面活性剤が好適である。As the surfactant used in combination to further increase the effects of the present invention, any of nonionic surfactants, anionic surfactants, and amphoteric surfactants can be used, but especially nonionic surfactants is suitable.
非イオン界面活性剤としては、例えば?リオキシエチレ
ンアルキルエーテル、?リオキシエチレンアルキルフェ
ニルエーテル、破すオキシエチレン脂肪酸エステル、ソ
ルビタン脂肪酸エステル、?リオキシエチレンソルビタ
ン脂肪酸エステル、脂肪酸モノグリセライド、グリセリ
ルエーテル等が挙げられる。その中でも、次の一般式(
W)
H
(式中 Bloは炭素数8〜24のアルキル基を示す)
で表わされるグリセリルエーテル、就中R1゜が次式<
X>
(式中、pは4〜10の整数、qは5〜11の整数を示
し、p+q=i l〜17でp=7、q=sを頂点とす
る分布を有する)
で表わされるものが特に好ましい。What are some examples of nonionic surfactants? Lioxyethylene alkyl ether,? Lyoxyethylene alkyl phenyl ether, breaking oxyethylene fatty acid ester, sorbitan fatty acid ester,? Examples include lyoxyethylene sorbitan fatty acid ester, fatty acid monoglyceride, and glyceryl ether. Among them, the following general formula (
W) Glyceryl ether represented by H (in the formula, Blo represents an alkyl group having 8 to 24 carbon atoms), in which R1° is the following formula <
X is particularly preferred.
界面活性剤の配合量は、全組成の0.01〜20%、特
に001〜5%が好ましい。The blending amount of the surfactant is preferably 0.01 to 20%, particularly 0.01 to 5% of the total composition.
本発明の皮膚外用剤は、その使用形態において、薬用皮
膚外用剤と化粧料に大別される。The skin external preparations of the present invention are broadly classified into medicated skin external preparations and cosmetics in terms of their usage forms.
薬用皮膚外用剤としては、例えば薬効成分を含有する各
種軟膏剤を挙げることができる。Examples of medicated skin external preparations include various ointments containing medicinal ingredients.
軟膏剤としては、油性基剤をペースとするもの、油/水
、水/油聾の乳化系基剤をベースとするもののいずれで
あってもよい。油性基剤としては、%に制限はなく、例
えば植物油、動物油、合成油、脂肪酸、及び天然又は合
成のグリセライド等が挙げられる。また薬効成分として
は、特に制限はなく、例えば鎮痛消炎剤、鎮痒剤、殺菌
消毒剤、収斂剤、皮膚軟化剤、ホルモン剤等を必要に応
じて適宜使用することができる。The ointment may be one based on an oily base, or one based on an emulsion base of oil/water or water/oil-deaf. The oily base is not limited in percentage and includes, for example, vegetable oils, animal oils, synthetic oils, fatty acids, natural or synthetic glycerides, and the like. There are no particular limitations on the medicinal ingredients, and for example, analgesic and antiinflammatory agents, antipruritic agents, sterilizing disinfectants, astringents, emollients, hormonal agents, and the like can be used as appropriate.
また、化粧料として使用する場合は、必須成分の他に化
粧料成分として一般に使用されている油分、保湿剤、紫
外線吸収剤、アルコール類、キレート剤、PH調整剤、
防腐剤、増粘剤、色素、香料等を任意に組合せて配合す
ることができる。In addition, when used as a cosmetic, in addition to the essential ingredients, oils, moisturizers, ultraviolet absorbers, alcohols, chelating agents, PH adjusters, etc. that are commonly used as cosmetic ingredients,
Preservatives, thickeners, pigments, fragrances, etc. can be blended in any combination.
化粧料としては、種々の形態、例えば水/油、油/水型
乳化化粧料、クリーム、化粧乳液、化粧水、油性化粧料
、口紅、ファウンデーション、皮膚洗浄剤、ヘアートニ
ック、整髪剤、養毛剤、育毛剤等の皮膚化粧料とするこ
とができる。Cosmetics can be used in various forms, such as water/oil, oil/water type emulsified cosmetics, creams, cosmetic emulsions, lotions, oil-based cosmetics, lipsticks, foundations, skin cleansers, hair tonics, hair styling products, hair tonics, etc. It can be used as a skin cosmetic such as a hair growth agent.
本発明皮膚外用剤における、成分(4)と成分(B)の
混合物の作用機構の詳細は完全には解明されていないが
、これが角質細胞間で水とともに脂質2重層を構築して
、角質層の水分保持機能を発揮するものと考えられる。Although the details of the mechanism of action of the mixture of component (4) and component (B) in the topical skin preparation of the present invention have not been completely elucidated, it builds a lipid bilayer with water between corneocytes and It is thought that it exerts a moisture retention function.
本発明皮膚外用剤は、このような作用を有する成分(蜀
と成分(B)の混合物を含有するものであるため、肌あ
れに対して優れた改善及び予防効果を発揮することがで
きる。Since the skin external preparation of the present invention contains a mixture of ingredients having such an action (a mixture of Shu and ingredient (B)), it can exhibit excellent improvement and preventive effects against rough skin.
次に参考例及び実施例を挙げて説明する。 Next, reference examples and examples will be given and explained.
参考例I
N−(2−ヒドロキシ−3−ヘキサテシロキシゾロビル
)−N−2−ヒドロキシエチルへキサデカナミド〔式(
1)におhて、 13=++(!。Ho、R’ : C
!、H,、のもの) (IJL)の合成:攪拌装置、滴
下漏斗、温度計、還流冷却器および窒素導入管を備えた
514ツロフラスコにエタノールアミン1637f(2
6,8モルフおよび、エタノール327t(7,11モ
ル)金入れ、窒素雰囲気下で80℃に加熱攪拌しつつ、
これにヘキサデシルグリシゾルエーテル400f(1,
34モル)t−3時間かけて滴下した。滴下終了後、更
゛た同条件下30分間加熱攪拌したのち、蒸留装置をと
シつけ、エタノールおよび、未反応のエタノールアミン
を減圧下に留去(79〜81 ’C/ 20 Torr
)した。80℃/ 20 Torrで加熱攪拌しつつ、
これに、ヘキサデカン酸メチル3613 f(L34モ
ル)を3時間かけて滴下した。滴1 C
下終了後、更に同条件下、1時間加熱攪拌することによ
り、淡黄色の粗生成物801fを得た。これをへキサン
から1回、エタノールから2回再結晶することにより、
無色粉末の目的化合物(1m) e 49 t (収率
81%)を得た。Reference Example I N-(2-hydroxy-3-hexatesiloxyzolobyl)-N-2-hydroxyethylhexadecanamide [Formula (
1) at h, 13=++(!.Ho, R': C
! , H, ) Synthesis of (IJL): Ethanolamine 1637f (2
6,8 morph and 327 t (7,11 mol) of ethanol in a gold pot, heated to 80°C under nitrogen atmosphere and stirred,
This was added to hexadecyl glycisol ether 400f (1,
(34 mol) was added dropwise over t-3 hours. After the dropwise addition was completed, the mixture was heated and stirred for 30 minutes under the same conditions, and then the distillation apparatus was turned on and ethanol and unreacted ethanolamine were distilled off under reduced pressure (79-81'C/20 Torr).
)did. While heating and stirring at 80°C/20 Torr,
To this, 3613 f (L34 mol) of methyl hexadecanoate was added dropwise over 3 hours. After dropping 1 C, the mixture was further heated and stirred for 1 hour under the same conditions to obtain pale yellow crude product 801f. By recrystallizing this once from hexane and twice from ethanol,
The target compound (1m) e 49 t (yield 81%) was obtained as a colorless powder.
実施例1
成分(A)と成分(B)の混合物の調製:化合物(Im
)を60重量%、コレステロール〔式(ff) :)
t 40重量%となるようにガラスネゾロのサンプル瓶
に計量する。サンプル瓶をヒーティング・ブロック等全
用いて150℃となるように加熱する。加゛熱して(I
m)及びコレステロールが完全に溶解したら、加熱を終
了し、空気中で放冷してペースト状態の混合物を得る。Example 1 Preparation of a mixture of component (A) and component (B): Compound (Im
), 60% by weight of cholesterol [formula (ff):)
Weigh into a glass Nezoro sample bottle so that the amount is 40% by weight. Heat the sample bottle to 150°C using a heating block and other devices. Heat it up (I
When m) and cholesterol are completely dissolved, the heating is finished and the mixture is left to cool in the air to obtain a paste-like mixture.
実施例2
ワセリンに実施例1で得た混合物を(Im)が15重量
%、コレステロールが10重量%になるように添加配合
して調製した皮膚外用剤(本発明品1)、ワセリンに上
記混合物を(Ia) カ15 K’1%、コレステロー
ルが10重量%になるように加え、更にグリセリルニー
7−ル(式(Iり中R1@ カ式(X) ノもの〕4重
量%を配合して調製した皮膚外用剤(本発明品2)、並
びにワセリン(対照)を用い、下記方法によシ皮膚コン
〆クタンス及び肌あれについて評価した。結果を第1表
に示す。Example 2 A skin external preparation prepared by adding and blending the mixture obtained in Example 1 to petrolatum so that (Im) was 15% by weight and cholesterol was 10% by weight (invention product 1), the above mixture was added to petrolatum. (Ia) was added so that the cholesterol content was 10% by weight, and 4% by weight of glyceryl nitride (Formula (R1 @ Formula (X))) was added. Using the skin external preparation (invention product 2) prepared by the above method and vaseline (control), the skin contactance and skin roughness were evaluated according to the following method.The results are shown in Table 1.
(試験方法)
冬期に頬部に肌あれを起こしている20〜〜50才の女
性10名を被験者とし、左右の頬に異なるサングルを毎
日1回2週間塗布する。2週間の塗布が終了した翌日に
次の項目につき試験を行なった。(Test Method) Ten women between the ages of 20 and 50 who suffer from rough skin on their cheeks during the winter were used as subjects, and different sunglasses were applied to the left and right cheeks once a day for two weeks. The next day after the two-week application was completed, the following tests were conducted.
(1)皮膚コンダクタンス
37℃の温水にて洗顔後、温度20℃、湿度40%の部
屋で20分間安静にした後、角質層の水分含有量を皮膚
コンダクタンスメーター(IBS社製)にて測定した。(1) Skin conductance After washing the face with warm water at 37°C and resting for 20 minutes in a room with a temperature of 20°C and humidity of 40%, the water content of the stratum corneum was measured using a skin conductance meter (manufactured by IBS). .
コンダクタンス値は値が小さいほど皮膚は肌あれし、5
以下ではひどい肌あれである。一方この値が20以上で
あれば肌あれはほとんど認められない。The smaller the conductance value, the rougher the skin;
Below, you can see the rough skin. On the other hand, if this value is 20 or more, skin roughness is hardly observed.
(2) 肌あれスコア
肌あれを肉眼で観測し、下記基準によシ判定した。スコ
アは平均値上標準偏差で示した。(2) Skin roughness score Skin roughness was observed with the naked eye and judged according to the following criteria. Scores are expressed as standard deviation above the mean.
(結果)
第1表
実施例3
化合物(1a)と、式(酌で示されるコレステロールと
、ステアリン酸〔式(■)で、R龜=CIT”amのも
の〕を第2表に示すように配合した水中油型乳化化粧料
を製造し、実施例2と同様な方法を用いて、皮膚コンダ
クタンス及び肌あれについて評価した。結果を第3表に
示す。(Results) Table 1 Example 3 Compound (1a), cholesterol indicated by the formula (chamber), and stearic acid [Formula (■), R cap = CIT"am] as shown in Table 2. A blended oil-in-water emulsion cosmetic was produced and evaluated for skin conductance and skin roughness using the same method as in Example 2. The results are shown in Table 3.
以下余白
第2表
(重量%)
第3表
実施例4
式(1)で示されるセラミド〔牛脳セラミド(フナコシ
薬品株式会社製)〕、コレステロールインステアレート
〔式(Y)中のR5が式(X)で示されるもの〕、ステ
アリン酸〔式(Vl)でR@” C+yHsjのもの〕
、2−エチルヘキサン酸トリグリセリド〔式(■)中R
’ =l’ =R”=CH,−(CH,) 、−C)i
−CH,のもの〕を第4表に示CH,−CH。Table 2 (% by weight) Table 3 Example 4 Ceramide represented by formula (1) [bovine brain ceramide (manufactured by Funakoshi Pharmaceutical Co., Ltd.)], cholesterol instearate [R5 in formula (Y) is the formula (X)], stearic acid [formula (Vl) with R@”C+yHsj]
, 2-ethylhexanoic acid triglyceride [R in formula (■)
'=l'=R''=CH, -(CH,), -C)i
-CH] are shown in Table 4. CH, -CH.
すように配合した水中油盤乳化化粧料を製造し、実施例
2と同様な方法を使って、皮膚インピーダンス及び肌あ
れKついて評価した6結果を第5表に示す。Table 5 shows the results of six evaluations of skin impedance and skin roughness K using the same method as in Example 2.
第4表
第5表
実施例5
皮膚外用剤(油性軟膏)
く組成〉
(1)ワセリン 30.0(
重量%)(2)セラミド(I)
to、。Table 4 Table 5 Example 5 Skin preparation (oil-based ointment) Composition> (1) Vaseline 30.0 (
Weight%) (2) Ceramide (I)
To,.
(3)コレステロール 3.0(
4)コレステロールイソステアレー)ZO(5)ステア
リン酸 4.0(6)オリブ油
全体が100となる量(7)t−
メントール 0.3(8)カンフ
ル 0・3く製造法〉
(1)、(7)〜(8)を混合し加熱溶解したものに1
別途(2)〜(6)を混合し加熱溶解したものを加え、
均一に混合し、室温付近まで冷却することによシ油性軟
膏を調製した。(3) Cholesterol 3.0 (
4) Cholesterol isostearate) ZO (5) Stearic acid 4.0 (6) Olive oil
Amount that makes the whole 100 (7) t-
Menthol 0.3 (8) Camphor 0.3 Production method> Add 1 to the mixed and heated mixture of (1), (7) to (8).
Separately, mix (2) to (6) and add the heated and dissolved mixture,
An oily ointment was prepared by uniformly mixing and cooling to around room temperature.
実施例6
化粧料(乳液)
く組成〉
油相成分:
マカデミアンナッツ油 zO(重量%)ス
クワラン &0
ステアリン酸 1.0化合物(1m
) 1.0大豆リン脂質
0.5グルコセレプロシド(牛脳抽出物)
0.5モノステアリン酸ンルピタン 0.5P
OE(60)硬化ヒマシ油 1.0水相成分:
グリセリン 1.0プロピレングリ
コール 1.0メチルノ9ラペン
0.3香 料
0.1精製水 全体′ft1
oOとする貴く製造法〉
油相成分を混合し、加熱溶解して70℃に保つ。水相成
分も同様に70”Cで加熱混合し、この水相成分に前述
の油相部を加えて乳化機にて乳化する。乳化物を熱交換
機にて終温30℃まで冷却したのを容器に充填して乳液
を調製した。Example 6 Cosmetic (emulsion) Composition> Oil phase components: Macadamian nut oil zO (wt%) squalane &0 stearic acid 1.0 compound (1 m
) 1.0 soy phospholipids
0.5 glucocereproside (bovine brain extract)
0.5 Monostearate Lupitan 0.5P
OE (60) Hydrogenated castor oil 1.0 Water phase components: Glycerin 1.0 Propylene glycol 1.0 Methyl-9-Lapen
0.3 fragrance
0.1 Purified water total'ft1
OO production method〉 Mix the oil phase components, heat and dissolve and keep at 70°C. The aqueous phase components are similarly heated and mixed at 70"C, and the aforementioned oil phase is added to this aqueous phase component and emulsified using an emulsifier. The emulsion is cooled to a final temperature of 30"C using a heat exchanger. A milky lotion was prepared by filling a container.
以上that's all
Claims (1)
ることのある炭素数10〜26の直鎖若しくは分岐鎖の
飽和若しくは不飽和の炭化水素基を示す) で表わされるセラミド又はその類似構造物質の一種又は
二種以上、 (B)コレステロール、コレステロール脂肪酸エステル
、脂肪酸、トリグリセリド、セレブロシド又はリン脂質
の一種又は二種以上、 を含有することを特徴とする皮膚外用剤。 2、(A)成分と(B)成分の配合比が、重量比で8:
2〜2:8である特許請求の範囲第1項記載の皮膚外用
剤。 3、更に界面活性剤を含有する特許請求の範囲第1項記
載の皮膚外用剤。[Claims] 1. The following components (A) and (B), (A) General formula (I) ▲There are numerical formulas, chemical formulas, tables, etc.▼(I) (In the formula, R^1 and R^ 2 represents a straight chain or branched chain saturated or unsaturated hydrocarbon group having 10 to 26 carbon atoms which may be substituted with one or more hydroxyl groups) or one or two of its similar structural substances. (B) A skin external preparation characterized by containing one or more of cholesterol, cholesterol fatty acid ester, fatty acid, triglyceride, cerebroside, or phospholipid. 2. The blending ratio of component (A) and component (B) is 8: by weight.
The skin external preparation according to claim 1, wherein the ratio is 2 to 2:8. 3. The skin external preparation according to claim 1, further comprising a surfactant.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2439187A JPS63192703A (en) | 1987-02-04 | 1987-02-04 | External agent for skin |
ES8800292A ES2013792A6 (en) | 1987-02-04 | 1988-02-02 | External agent for skin |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2439187A JPS63192703A (en) | 1987-02-04 | 1987-02-04 | External agent for skin |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS63192703A true JPS63192703A (en) | 1988-08-10 |
JPH0459285B2 JPH0459285B2 (en) | 1992-09-21 |
Family
ID=12136865
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2439187A Granted JPS63192703A (en) | 1987-02-04 | 1987-02-04 | External agent for skin |
Country Status (2)
Country | Link |
---|---|
JP (1) | JPS63192703A (en) |
ES (1) | ES2013792A6 (en) |
Cited By (37)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0278505A2 (en) * | 1987-02-12 | 1988-08-17 | Estee Lauder Inc. | Hair protection composition and method |
JPH0366604A (en) * | 1989-08-04 | 1991-03-22 | Kanebo Ltd | Dermal cosmetic |
JPH03258710A (en) * | 1990-03-07 | 1991-11-19 | Q P Corp | Cosmetic |
US5087418A (en) * | 1987-02-25 | 1992-02-11 | Adir Jacob | Process for dry sterilization of medical devices and materials |
FR2667241A1 (en) * | 1991-07-18 | 1992-04-03 | Pola Kasei Kogyo Kk | Scalp moisturiser and external preparation for the skin |
FR2675045A1 (en) * | 1991-04-10 | 1992-10-16 | Carita Sa | Cosmetic composition having an antidehydrating effect which is usable in lipsticks |
US5198210A (en) * | 1990-10-22 | 1993-03-30 | Elizabeth Arden Company, Division Of Conopco, Inc. | Cosmetic composition |
US5206020A (en) * | 1991-01-15 | 1993-04-27 | Elizabeth Arden Company, Division Of Conopco, Inc. | Synthetic pseudoceramide and cosmetic compositions thereof |
EP0554897A2 (en) * | 1992-02-05 | 1993-08-11 | Kao Corporation | Novel sterol derivative, process for producing the same and dermatologic external preparation |
FR2690343A1 (en) * | 1992-04-28 | 1993-10-29 | Inocosm Laboratoires | Compsn. with anti-radical and anti-lipo-peroxidising effect contg. polar lipid - for use in cosmetics, dietetics, food industry and pharmacology |
JPH0680555A (en) * | 1992-01-23 | 1994-03-22 | Unilever Nv | Cosmetics composition |
WO1995013791A1 (en) * | 1993-11-15 | 1995-05-26 | Unilever Plc | Ceramide cosmetic compositions |
WO1995029151A1 (en) * | 1994-04-27 | 1995-11-02 | Gist-Brocades B.V. | Short chain 2-hydroxycarboxylic acid-based derivatives of ceramides |
WO1996012469A1 (en) * | 1994-10-20 | 1996-05-02 | Unilever Plc | Personal care composition |
WO1996016635A1 (en) * | 1994-11-28 | 1996-06-06 | Gist-Brocades B.V. | Topical application of ceramides |
JPH08508742A (en) * | 1993-04-20 | 1996-09-17 | ユニリーバー・ナームローゼ・ベンノートシヤープ | Cosmetic composition containing ceramide precursor |
JPH08245337A (en) * | 1995-02-15 | 1996-09-24 | L'oreal Sa | Cosmetic composition containing ceramides and method for use of it |
US5565207A (en) * | 1990-09-19 | 1996-10-15 | Pola Kasei Kogyo Kabushiki Kaisha | Scalp moisturizer and external skin preparation |
WO1997014401A1 (en) * | 1995-10-16 | 1997-04-24 | Kao Corporation | Skin and hair cosmetic compositions |
EP0775482A2 (en) | 1995-10-30 | 1997-05-28 | Unilever Plc | Cosmetic compositions containing tricholine citrate |
EP0866693A1 (en) * | 1995-10-18 | 1998-09-30 | Mary Kay Inc. | Topically applied, structural cellulite treatments |
AU725037B2 (en) * | 1996-03-25 | 2000-10-05 | Fd Management, Inc. | Long wearing lipstick |
US6221371B1 (en) | 1996-11-11 | 2001-04-24 | Aekyung Industrial Co., Inc. | Pseudoceramides, and dermatologic external preparations containing the same |
JP2001220345A (en) * | 2000-02-07 | 2001-08-14 | Noevir Co Ltd | Epidermal ceramide formation promoter and epidermal moisture retention-improving agent containing the same |
KR100371491B1 (en) * | 1999-07-27 | 2003-02-07 | 주식회사 두산 | Cream Composition For Skin Care |
US6521241B1 (en) | 1998-12-31 | 2003-02-18 | Kimberly-Clark Worldwide, Inc. | Substrate composition for sequestration of skin irritants |
WO2004045566A1 (en) * | 2002-11-15 | 2004-06-03 | Kose Corporation | Semitransparent cosmetics |
JP2006273747A (en) * | 2005-03-29 | 2006-10-12 | Kose Corp | O/w/o type emulsion cosmetic |
JP2007001950A (en) * | 2005-06-27 | 2007-01-11 | Pola Chem Ind Inc | Ceramide-containing skin external preparation |
CN1332641C (en) * | 2002-07-05 | 2007-08-22 | 株式会社高丝 | Vesicle dispersion and cosmetic containing the same |
WO2008105475A1 (en) * | 2007-03-01 | 2008-09-04 | Takasago International Corporation | Lipid composition having excellent shape retention property and product |
JP2008244857A (en) * | 2007-03-27 | 2008-10-09 | National Institutes Of Natural Sciences | Waveguide connector |
JP2008297301A (en) * | 2007-05-01 | 2008-12-11 | Fancl Corp | Ceramide solution and dermatological preparation for external use |
US7846969B2 (en) | 2001-12-10 | 2010-12-07 | Kao Corporation | Ceramide emulsions |
US8313755B2 (en) | 2000-05-11 | 2012-11-20 | Takasago International Corporation | Clear aqueous ceramide composition |
JP2014189542A (en) * | 2013-03-28 | 2014-10-06 | Kao Corp | Method for producing amide derivative |
JP2016190817A (en) * | 2015-03-31 | 2016-11-10 | 小林製薬株式会社 | External composition |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU670613B2 (en) * | 1992-06-19 | 1996-07-25 | Regents Of The University Of California, The | Lipids for epidermal moisturization and repair of barrier function |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS61271205A (en) * | 1985-05-24 | 1986-12-01 | Kanebo Ltd | Skin cosmetic |
JPS61289013A (en) * | 1985-06-18 | 1986-12-19 | Pola Chem Ind Inc | Skin external agent |
JPS63141908A (en) * | 1986-12-03 | 1988-06-14 | Kanebo Ltd | Emulsion-type cosmetic |
-
1987
- 1987-02-04 JP JP2439187A patent/JPS63192703A/en active Granted
-
1988
- 1988-02-02 ES ES8800292A patent/ES2013792A6/en not_active Expired - Fee Related
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS61271205A (en) * | 1985-05-24 | 1986-12-01 | Kanebo Ltd | Skin cosmetic |
JPS61289013A (en) * | 1985-06-18 | 1986-12-19 | Pola Chem Ind Inc | Skin external agent |
JPS63141908A (en) * | 1986-12-03 | 1988-06-14 | Kanebo Ltd | Emulsion-type cosmetic |
Cited By (48)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0278505A2 (en) * | 1987-02-12 | 1988-08-17 | Estee Lauder Inc. | Hair protection composition and method |
US5087418A (en) * | 1987-02-25 | 1992-02-11 | Adir Jacob | Process for dry sterilization of medical devices and materials |
JPH0366604A (en) * | 1989-08-04 | 1991-03-22 | Kanebo Ltd | Dermal cosmetic |
JPH03258710A (en) * | 1990-03-07 | 1991-11-19 | Q P Corp | Cosmetic |
US5565207A (en) * | 1990-09-19 | 1996-10-15 | Pola Kasei Kogyo Kabushiki Kaisha | Scalp moisturizer and external skin preparation |
US5198210A (en) * | 1990-10-22 | 1993-03-30 | Elizabeth Arden Company, Division Of Conopco, Inc. | Cosmetic composition |
US5326565A (en) * | 1990-10-22 | 1994-07-05 | Elizabeth Arden Co. | Cosmetic composition |
US5206020A (en) * | 1991-01-15 | 1993-04-27 | Elizabeth Arden Company, Division Of Conopco, Inc. | Synthetic pseudoceramide and cosmetic compositions thereof |
FR2675045A1 (en) * | 1991-04-10 | 1992-10-16 | Carita Sa | Cosmetic composition having an antidehydrating effect which is usable in lipsticks |
FR2667241A1 (en) * | 1991-07-18 | 1992-04-03 | Pola Kasei Kogyo Kk | Scalp moisturiser and external preparation for the skin |
JPH0680555A (en) * | 1992-01-23 | 1994-03-22 | Unilever Nv | Cosmetics composition |
EP0554897A2 (en) * | 1992-02-05 | 1993-08-11 | Kao Corporation | Novel sterol derivative, process for producing the same and dermatologic external preparation |
EP0554897A3 (en) * | 1992-02-05 | 1996-11-27 | Kao Corp | Novel sterol derivative, process for producing the same and dermatologic external preparation |
EP0846698A1 (en) * | 1992-02-05 | 1998-06-10 | Kao Corporation | Dermatologic external preparation |
FR2690343A1 (en) * | 1992-04-28 | 1993-10-29 | Inocosm Laboratoires | Compsn. with anti-radical and anti-lipo-peroxidising effect contg. polar lipid - for use in cosmetics, dietetics, food industry and pharmacology |
JPH08508742A (en) * | 1993-04-20 | 1996-09-17 | ユニリーバー・ナームローゼ・ベンノートシヤープ | Cosmetic composition containing ceramide precursor |
WO1995013791A1 (en) * | 1993-11-15 | 1995-05-26 | Unilever Plc | Ceramide cosmetic compositions |
WO1995029151A1 (en) * | 1994-04-27 | 1995-11-02 | Gist-Brocades B.V. | Short chain 2-hydroxycarboxylic acid-based derivatives of ceramides |
US5688752A (en) * | 1994-10-20 | 1997-11-18 | Lever Brothers Company, Division Of Conopco, Inc. | Aqueous personal care cleanser comprising specific lipid composition |
WO1996012469A1 (en) * | 1994-10-20 | 1996-05-02 | Unilever Plc | Personal care composition |
CN1096844C (en) * | 1994-10-20 | 2002-12-25 | 尤尼利弗公司 | Personal care composition |
WO1996016635A1 (en) * | 1994-11-28 | 1996-06-06 | Gist-Brocades B.V. | Topical application of ceramides |
JPH08245337A (en) * | 1995-02-15 | 1996-09-24 | L'oreal Sa | Cosmetic composition containing ceramides and method for use of it |
JP2922150B2 (en) * | 1995-02-15 | 1999-07-19 | ロレアル | Cosmetic composition containing ceramides and method of using the same |
WO1997014401A1 (en) * | 1995-10-16 | 1997-04-24 | Kao Corporation | Skin and hair cosmetic compositions |
EP0866693A1 (en) * | 1995-10-18 | 1998-09-30 | Mary Kay Inc. | Topically applied, structural cellulite treatments |
EP0866693A4 (en) * | 1995-10-18 | 1999-10-06 | Mary Kay Inc | Topically applied, structural cellulite treatments |
EP0775482A2 (en) | 1995-10-30 | 1997-05-28 | Unilever Plc | Cosmetic compositions containing tricholine citrate |
AU725037B2 (en) * | 1996-03-25 | 2000-10-05 | Fd Management, Inc. | Long wearing lipstick |
US6221371B1 (en) | 1996-11-11 | 2001-04-24 | Aekyung Industrial Co., Inc. | Pseudoceramides, and dermatologic external preparations containing the same |
US6551607B1 (en) | 1998-12-31 | 2003-04-22 | Kimberly-Clark Worldwide, Inc. | Method for sequestration of skin irritants with substrate compositions |
US6521241B1 (en) | 1998-12-31 | 2003-02-18 | Kimberly-Clark Worldwide, Inc. | Substrate composition for sequestration of skin irritants |
KR100371491B1 (en) * | 1999-07-27 | 2003-02-07 | 주식회사 두산 | Cream Composition For Skin Care |
JP2001220345A (en) * | 2000-02-07 | 2001-08-14 | Noevir Co Ltd | Epidermal ceramide formation promoter and epidermal moisture retention-improving agent containing the same |
US8313755B2 (en) | 2000-05-11 | 2012-11-20 | Takasago International Corporation | Clear aqueous ceramide composition |
US7846969B2 (en) | 2001-12-10 | 2010-12-07 | Kao Corporation | Ceramide emulsions |
CN1332641C (en) * | 2002-07-05 | 2007-08-22 | 株式会社高丝 | Vesicle dispersion and cosmetic containing the same |
WO2004045566A1 (en) * | 2002-11-15 | 2004-06-03 | Kose Corporation | Semitransparent cosmetics |
JPWO2004045566A1 (en) * | 2002-11-15 | 2006-03-16 | 株式会社コーセー | Translucent cosmetics |
JP4504195B2 (en) * | 2002-11-15 | 2010-07-14 | 株式会社コーセー | Translucent cosmetics |
JP2006273747A (en) * | 2005-03-29 | 2006-10-12 | Kose Corp | O/w/o type emulsion cosmetic |
JP2007001950A (en) * | 2005-06-27 | 2007-01-11 | Pola Chem Ind Inc | Ceramide-containing skin external preparation |
WO2008105475A1 (en) * | 2007-03-01 | 2008-09-04 | Takasago International Corporation | Lipid composition having excellent shape retention property and product |
US8846651B2 (en) | 2007-03-01 | 2014-09-30 | Takasago International Corporation | Lipid composition having excellent shape retention property and product |
JP2008244857A (en) * | 2007-03-27 | 2008-10-09 | National Institutes Of Natural Sciences | Waveguide connector |
JP2008297301A (en) * | 2007-05-01 | 2008-12-11 | Fancl Corp | Ceramide solution and dermatological preparation for external use |
JP2014189542A (en) * | 2013-03-28 | 2014-10-06 | Kao Corp | Method for producing amide derivative |
JP2016190817A (en) * | 2015-03-31 | 2016-11-10 | 小林製薬株式会社 | External composition |
Also Published As
Publication number | Publication date |
---|---|
ES2013792A6 (en) | 1990-06-01 |
JPH0459285B2 (en) | 1992-09-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPS63192703A (en) | External agent for skin | |
EP0534286B1 (en) | External skin care preparation | |
US4278657A (en) | Creamy or milky skin cosmetic compositions containing natural materials as emulsifying agents | |
JPH04327563A (en) | Ceramide, method of manufacturing same and cosmetic composition | |
JPS6115809A (en) | Cell activator | |
JPS63192704A (en) | Cosmetic | |
JPS62228048A (en) | Amide derivative and dermatic external drug containing same | |
CN106413681A (en) | Ceramide-formulated external agent composition | |
JPS6026086B2 (en) | cosmetics | |
JPS61204109A (en) | Emulsion-type composition for external use | |
JPH08109121A (en) | Cosmetic | |
JPS63216812A (en) | Skin drug for external use | |
JPS6026087B2 (en) | cosmetics | |
JP4112741B2 (en) | Moisturizer | |
JPS62204842A (en) | Oil in water type emulsified composition | |
JPS63227513A (en) | Dermatic drug for external application | |
JP2741143B2 (en) | External preparation for skin | |
JPS617205A (en) | Cell activator | |
JPS6023307A (en) | Skin beautifying cosmetic | |
JPS58128310A (en) | Skin conditioner | |
JPS63208505A (en) | Cosmetic | |
JP2609884B2 (en) | Skin cosmetics | |
WO2005099682A1 (en) | Preparations for external use | |
JPH07106974B2 (en) | Topical skin | |
JPS62132808A (en) | Hair-forming, hair-growing agent |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
EXPY | Cancellation because of completion of term |